Aridis Pharmaceuticals Inc (ARDS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Sales | 1,022 | 22 | 322 | 0 | 22 |
| Gross Profit | 1,022 | 22 | 322 | N/A | 22 |
| Operating Expenses | 7,642 | 4,572 | 7,692 | 0 | 5,508 |
| Operating Income | -6,620 | -4,550 | -7,370 | N/A | -5,486 |
| Other Income | -1,289 | 3,126 | 36 | 0 | 68 |
| Pre-tax Income | -7,909 | -1,424 | -7,334 | 0 | -5,418 |
| Net Income Continuous | -7,909 | -1,424 | -7,334 | N/A | -5,418 |
| Net Income | $-7,909 | $-1,424 | $-7,334 | $N/A | $-5,418 |
| EPS Basic Total Ops | -1.97 | -11.78 | -48.99 | N/A | -37.30 |
| EPS Basic Continuous Ops | -1.97 | -8.56 | -44.08 | N/A | -32.57 |
| EPS Diluted Total Ops | -1.97 | -11.78 | -48.99 | N/A | -37.30 |
| EPS Diluted Continuous Ops | -1.97 | -8.56 | -44.08 | N/A | -32.57 |
| EBITDA(a) | $-6,544 | $-4,477 | $-7,319 | $N/A | $-5,472 |